DHAI DIH Holding: Enterprise Value-to-Revenue Multiple

Public company logo of DIH Holding (DHAI)

The EV/Revenue multiple for DIH Holding US, Inc. (DHAI) shows a downward trend, driven by potential cuts in hospital spending on robotics. The current figure stands at . Demand is supported by an aging population, despite the moderate cyclicality of the industry. Business stability is ensured by diversified imports of electronic components, which minimizes logistical disruptions in the delivery of rehabilitation systems.

dih.com (DHAI) - EV/Sales Multiple from 07/04/2022 to 11/20/2026

DHAI (DIH Holding US, Inc.): analytical breakdowns and indicator data

- current price and projected stock value:
- company stock capitalization data:
- money and cash flow information:
Fundamental company valuation:DHAI DIH Holding
Original product of DIH Group

This indicator determines business value through the ratio of total enterprise value to revenue, excluding the impact of debt load to identify the asset's net market attractiveness. By analyzing the EV/Sales chart, an investor can compare the fundamental value of DIH Holding US, Inc. (DHAI) with the expansion of its robotic systems in hospitals, allowing for an assessment of sales scaling efficiency and confirmation of the long-term potential for capitalization growth.

Direct competitors

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|EV/Sales Multiple BTMD (Biote)|Enterprise Value-to-Revenue Coefficient JYNT (The Joint Corp.)|DCGO - Enterprise Value-to-Revenue Ratio|PIII: Enterprise Value-to-Revenue Ratio|GANX: EV/Sales Multiple|Company Value to Revenue EUDA Health|BMGL (Basel Medical Group) - EV/Sales Multiple|CLGN - Enterprise Value-to-Sales Ratio|Enterprise Value-to-Revenue Ratio Cuprina Holdings (CUPR)|Total Company Value-to-Revenue Ratio Concord Medical Services|EV/Sales Multiple AMS (ashs.com)|MEDIROM Healthcare Group Inc. (MRM) - Enterprise Value-to-Revenue Multiple|ALBT: Company Value to Revenue|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple